NCT01748279View on ClinicalTrials.gov

The Effects of Atorvastatin Treatment in COPD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
COPD
Interventions
DRUG

Atorvastatin

DRUG

Formoterol

12mcg of Foradil BID as maintenance COPD treatment in both treatment arms

DRUG

Lactose tablet

One lactose tablet taken once a day as add-on treatment to Formoterol therapy

Trial Locations (1)

15-540

Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok

All Listed Sponsors
lead

Medical University of Bialystok

OTHER

NCT01748279 - The Effects of Atorvastatin Treatment in COPD Patients | Biotech Hunter | Biotech Hunter